Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry With The Highest Revenue Estimates

Below are the top small-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year. Analysts expect Alere ALR to post revenue of $2.78 billion for the year ending December, 2012. Alere had $303.15 million in total cash for the latest quarter. ICON Public Limited Company ICLR is likely to post revenue of $1.10 billion in the year ending December, 2012. ICON's trailing-twelve-month operating margin is 5.29%. Bio-Reference Laboratories BRLI may report revenue of $651.40 million in the current year. Bio-Reference Laboratories' PEG ratio is 0.90. Alliance Healthcare Services AIQ is expected to report revenue of $487.02 million for the year ending December, 2012. Alliance Healthcare's trailing-twelve-month ROA is 4.51%.